A team of researchers from the US and Canada projected forward the incidence of Covid-19 cases under a range of vaccine dosing regimes, vaccination rates, and assumptions related to immune responses.
B.1.617.2, or the Delta variant of covid causing Sars Cov2 was the dominant circulating strain and one of the primary drivers for the country's covid second wave.
There has been a rise in the number of deaths and new COVID-19 infections driven in large part by the highly infectious Delta variant in Sri Lanka.
As per the data released on Wednesday, there were 65 patients infected with the Delta plus variant in the entire state. Seven of them were from Mumbai.
Researchers from the Mayo Clinic in Minnesota, US, found that the Pfizer-BioNTech vaccine was only 42 percent effective against infection in July, while the Moderna vaccine was only 76 percent effective.
Of the fresh cases, the maximum - seven - are from Mumbai, followed by three from Pune, two each from Palghar, Raigad, Nanded, and Gondia, and one each from Akola and Chandrapur districts.
Delta variant has been found in 1,689 of the 5,752 samples from Delhi processed at the National Centre for Disease Control (NCDC) so far.
A total of 30 cases of COVID-19 Delta Variant have been detected in Maharashtra after which 13 villages in the state were instructed to raise awareness and take precautions. Maharastra government has scheduled a review meeting today at 11 AM.
The samples were sent for genome sequencing to Pune, after which all the samples tested positive for the Delta variant.
The company added that its Covid-19 vaccine does not wane away and remains durable through six months after the second dose. The result of its clinical trial, which started in late July 2020 and recruited 30,000 volunteers, showing 94.1 percent efficacy did not change much after six months, the company said in a statement.
In its latest update on Wednesday, the CDC said that this number is even higher in certain parts of the country, showed the updated figures for the week ending July 31, reports Xinhua news agency.
With the fresh mutant of Delta variant spreads out in Himalayan Nation exceeding cases of daily infection, shelter for COVID-19 patients has been set up at Sukraraj Tropical and Infectious Disease Hospital. From beds to oxygen cylinders, everthing has been lined up following the growing cases of Delta COVID variant. Sukraraj Tropical Hospital which has capacity of 100 general beds patients have been admitted in 35 beds while 22 of its 28 ICU beds has been occupied.
Mayor Bill de Blasio announced the new requirements on Tuesday, making New York the first big city in the US to draw these battle lines as Covid delta variant surges.
Viruses constantly mutate, and most changes aren't concerning. But the worry is that unchecked spread could fuel mutations and produce a variant that's even more contagious, causes more severe illness or evades the protection that vaccines provide.
The team from National University of Singapore (NUS) found that a combination of antiviral molnupiravir and anti-inflammatory baricitinib can be effective against the Beta and Delta variants of the virus, the Strait Times reported.
Data from the Centers for Disease Control and Prevention showed that cases of RSV have risen gradually since early June, with an even greater spike in the past month, the New York Times reported. RSV leads to runny nose, coughing, sneezing and fever.
The World Health Organisation has announced an 80 percent average increase over the past four weeks in five of the health agency's six regions, a jump largely fuelled by the Delta variant.
The CDC updated its masking recommendation on Tuesday, urging vaccinated Americans to resume wearing masks in schools and in public indoor spaces in Covid-19 hot spots across the country.
The document from the Centers for Disease Control and Prevention (CDC) outlines unpublished data that shows fully vaccinated people might spread the Delta variant, first identified in India, at the same rate as unvaccinated people.
Antibody levels against the Delta variant in people aged 18 to 55 who receive a third dose of the Pfizer/BioNTech vaccine are greater than five-fold than following a second dose, according to data posted at the company's teleconference, Xinhua reported.
Top News
Latest News
